Marechale Capital (LSE:MAC) Research & Development: £0.00 Mil (TTM As of Oct. 2025)


What is Marechale Capital Research & Development?

Marechale Capital LSE:MAC Research & Development is £0.00 Mil as of Oct. 2025. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Marechale Capital's Research & Development for the six months ended in Oct. 2025 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2025 was £0.00 Mil.

Marechale Capital  (LSE:MAC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Marechale Capital Research & Development Related Terms

Marechale Capital Research & Development Historical Data

* Premium members only.

The historical data trend for Marechale Capital's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marechale Capital Research & Development Chart

Marechale Capital Annual Data
Trend Mar15 Mar16 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Marechale Capital Semi-Annual Data
Sep15 Mar16 Sep16 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24 Oct24 Apr25 Oct25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Marechale Capital Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.00 Mil mean?
Marechale Capital (LSE:MAC) has a Research & Development of £0.00 Mil as of Oct. 2025. Research and development expense is the total cost for research and development activities. View historical data on Marechale Capital and its competitors.
Is Marechale Capital's Research & Development too high?
Marechale Capital's current Research & Development is £0.00 Mil.
How does Marechale Capital's Research & Development compare to MS and GS?
Marechale Capital's Research & Development of £0.00 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Capital Markets company?
A good Research & Development depends on the Capital Markets industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Marechale Capital and its competitors. Marechale Capital's current Research & Development is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marechale Capital stock overvalued right now?
Based on GuruFocus' analysis, Marechale Capital (LSE:MAC) is currently considered Significantly Overvalued. The stock's GF Value™ is £0.01, compared to a current price of £0.07 — trading 600% above its estimated fair value. The current Research & Development is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Marechale Capital (LSE:MAC), the current Research & Development is £0.00 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Marechale Capital Business Description

Address 46 New Broad Street, London, GBR, EC2M 1JH
Marechale Capital PLC is an investment banking and corporate finance company. The company's business includes the provision of advisory and brokerage services. It offers its services to sectors including consumer, leisure and retail, infrastructure, online exchanges, and private equity and asset-backed funds.